Drug Topics

JANUARY 24, 2025

Jonathan Watanabe, PharmD, MS, PhD, BCGP, joined Drug Topics to discuss how pharmacists can facilitate improved patient outcomes through collaborative care.

432

432

STAT

JANUARY 24, 2025

Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians to prescribe a migraine treatment. The alleged violations occurred before Pfizer bought the company three years ago, according to the U.S. Department of Justice. The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to

137

137

Drug Topics

JANUARY 24, 2025

Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.

359

359

PharmaVoice

JANUARY 24, 2025

Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the belief the answer could come down to delivery.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 24, 2025

Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, provides best tips and practices for providing maternity care.

247

247

STAT

JANUARY 24, 2025

The federal government is officially backing down from a courtroom fight with the country’s largest Medicare Advantage insurer, just three days after it said it was ready to spar.

Insurance 145

Insurance 145

Fierce Healthcare

JANUARY 24, 2025

Change Healthcare now estimates that 190 million people were impacted in the massive cyberattack that took down its services nearly a year ago. | Change Healthcare now estimates that 190 million people were impacted in the massive cyberattack that took down its services nearly a year ago.

138

138

PhRMA

JANUARY 24, 2025

It has been widely acknowledged that long patent examination delays cripple innovation, hinder economies, impede job creation and frustrate the launch of new products. Increased patent review times cost the global economy $10 billion annually, and are particularly harmful for small start-up firms. Every year of delay reduces the start-up’s employment growth by 21% and sales growth by 28% over the five years following the approval of the patent application.

130

130

Pharmacy Times

JANUARY 24, 2025

These data suggest the potential efficacy of immune checkpoint inhibitors with anthracycline-based chemotherapy.

Chemotherapy 121

Chemotherapy Immunization 121

Pharmaceutical Technology

JANUARY 24, 2025

The settlement ends the Sackler familys ownership of the Oxycontin developer Purdue Pharma.

111

111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 24, 2025

Biosimilar use is not linked to an increased risk of treatment failure among pediatric patients with inflammatory bowel disease (IBD).

118

118

pharmaphorum

JANUARY 24, 2025

UnitedHealth has appointed company veteran Tim Noel as CEO of its UnitedHealthcare insurance unit, after the murder last month of Brian Thompson.

Insurance 105

Insurance 105

Pharmacy Times

JANUARY 24, 2025

Abelacimab (Anthos Therapeutics Inc) is a novel factor XI inhibitor being investigated for the reduction of bleeding for patients with atrial fibrillation.

116

116

pharmaphorum

JANUARY 24, 2025

Purdue Pharma and the Sackler family who own the company have proposed a new $7.

104

104

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

JANUARY 24, 2025

The FDA rejected the companys initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.

FDA 102

FDA 102

pharmaphorum

JANUARY 24, 2025

Explore the lessons learned from 2024 in pharmacy benefits, including the impact of polypharmacy, biosimilars, and GLP-1 medications, and what to expect for 2025 in this insightful article.

100

100

The Checkup by Singlecare

JANUARY 24, 2025

About 30 million adults in the U.S. have an underactive thyroid, which means their thyroid gland doesnt produce enough thyroid hormones to keep up with the bodys demands. Thyroid-stimulating hormone (TSH) is a pituitary hormone that stimulates your thyroid to produce the thyroid hormones thyroxine (T4) and triiodothyronine (T3). T3 and T4 are responsible for regulating your metabolism, body temperature, growth, and energy levels.

Dosage 97

Dosage 97

pharmaphorum

JANUARY 24, 2025

Shares in Novo Nordisk have risen sharply on new weight-loss data with an injectable formulation of new obesity candidate amycretin.

95

95

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 24, 2025

Behavioral health tech company Eleos Health doubled its lifetime funding, which now totals $120 million, with its most recent raise. The company plans to use the funding to add new features to its clinical documentation solutions and expand into substance use treatment centers.

Documentation 79

Documentation 79

pharmaphorum

JANUARY 24, 2025

AstraZeneca has announced another major investment in Canada, tapping into the country's emergence as a "global hub" for clinical trials.

95

95

Pharmacy Times

JANUARY 24, 2025

Pharmacists can play an important role in tobacco cessation.

73

73

Pharmaceutical Technology

JANUARY 24, 2025

The funds will support the development of Ascentages pipeline, including its lead candidate olverembatinib to treat blood cancer.

64

64

Pharmacy Times

JANUARY 24, 2025

The report highlights perspective from 4 key stakeholders of patients, specialty pharmacies and providers, biopharmaceutical industry, and public and private payers.

Specialty Pharmacies 73

Specialty Pharmacies 73

Pharmaceutical Technology

JANUARY 24, 2025

The FDA has granted approval for the ANDA of Lupins Sacubitril and Valsartan Tablets for heart failure patients.

FDA 59

FDA 59

Pharmacy Times

JANUARY 24, 2025

Pharmacists bridge communication gaps and enhance shared decision-making.

Communication 73

Communication 73

pharmaphorum

JANUARY 24, 2025

Learn how companies are rethinking their digital transformation budgets for 2025 and realigning expectations to effectively leverage technology for business growth.

59

59

Pharmacy Times

JANUARY 24, 2025

Endocrine-immune-based therapies yielded favorable objective response rates but had limited impact on pathological complete response.

Immunization 65

Immunization 65

pharmaphorum

JANUARY 24, 2025

Spotify founder Daniel Ek's new business Neko Health has raised $260m to bring its body scanning clinics to new international markets

59

59

Pharmacy Times

JANUARY 24, 2025

The FDA is modernizing its approach to drug development and optimization.

FDA 65

FDA 65

Pharmaceutical Commerce

JANUARY 24, 2025

The latest news for pharma industry insiders.

59

59

Pharmacy Times

JANUARY 24, 2025

Patients recovering from COVID-19 and caregivers reported how some social determinants of health were helpful in their recovery, while others led to difficult social and mental challenges.

65

65

Pharmaceutical Commerce

JANUARY 24, 2025

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, describes how she supports her organizations channel strategy.

59

59

Pharmacy Times

JANUARY 24, 2025

Point-of-care testing implementation could provide valuable data on community respiratory syncytial virus incidence and enhance sentinel surveillance efforts.

65

65